News
Swiss pharma giant Roche says its new antibiotic zosurabalpin will progress to phase 3 testing. It’s the first drug in its ...
Researchers have created a pipeline for discovering unique combinations of molecules that increase the effectiveness of antibiotics against drug-resistant bacteria. The team, led by scientists at the ...
A review in Biomolecules and Biomedicine sheds light on how microRNAs (miRNAs)—small regulatory RNA molecules—play a central ...
Roche (RHHBY) is planning to move a new antibiotic into late stage clinical trials after early studies showed it had ...
A research team affiliated with UNIST has unveiled a novel extracorporeal blood purification technology that captures and ...
Roche is planning to move a new antibiotic into late-stage clinical trials after studies showed it had potential to tackle a ...
An experimental antibiotic zosurabalpin to fight deadly superbug has entered the final human trials. This development could ...
Roche is moving its novel antibiotic zosurabalpin into phase 3 testing for carbapenem-resistant Acinetobacter baumannii (CRAB), a 'superbug' that is considered an 'urgent threat' by the CDC, in what ...
Abstract Extracorporeal hemoadsorption for treating bacteremia has exhibited limited success due to the lack of a clear strategy for effectively ...
aClinic of Respiratory Medicine and Pulmonary Cell Research, University Hospital Basel, Basel, Switzerland bDivision of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, ...
According to a new study, researchers have developed a 3D-printed stent designed to treat urinary tract infections (UTIs) ...
Recce Pharmaceuticals secures patent acceptance in China for synthetic anti-infectives as it targets growing global health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results